Back to Search
Start Over
[Osteoporosis and cardiovascular disease--two sides of the same coin?].
- Source :
-
Medizinische Klinik (Munich, Germany : 1983) [Med Klin (Munich)] 2003 Aug 15; Vol. 98 (8), pp. 437-46. - Publication Year :
- 2003
-
Abstract
- Background: Osteoporosis and cardiovascular disease have numerous epidemiologic changes, health economic consequences, and molecular mechanisms in common, which are highlighted in this short review.<br />Epidemiology and Clinical Studies: The incidence of osteoporosis and cardiovascular disease is increasing in western societies, and genetic background, nutrition and psychologic factors play important roles in the pathogenesis of both diseases. The presence of a decreased bone mass or osteoporotic vertebral fractures are associated with an increased cardiovascular mortality. Calcaneal bone loss of 1 SD (standard deviation) as measured by osteodensitometry is associated with a 1.31 times increased risk for the occurrence of stroke.<br />Molecular Mechanisms: The observed increase in interleukin-6 and tumor necrosis factor serum concentrations during the menopause contributes to osteoporotic bone loss and is associated with arteriosclerosis. Furthermore, the presence of hydroxyapatite in arteriosclerotic plaques supports the notion of common pathogenetic mechanisms for both, osteoporosis and arteriosclerosis. Osteopontin, bone GLA protein and bone morphogenetic protein-2, which have first been isolated from the organic bone matrix, are also present in arteriosclerotic plaques. 1,25-dihydroxycholecalciferol potently stimulates bone matrix mineralization and is also a negative regulator of the renin-angiotensin system; therefore vitamin D(3) deficiency in addition to bone metabolism also affects blood pressure. Osteoporosis and arteriosclerosis develop in mice lacking the osteoprotegerin gene and also in klotho gene knockout mice.<br />Conclusion: Diagnosis of osteopenia, osteoporosis and osteoporotic vertebral or hip fractures indicates the presence of an increased cardiovascular risk which needs to be addressed by the physician who cares for patients with osteoporosis. The experimental finding of an osteoanabolic effect of statins supports the possibility of common pathogenetic disturbances which may be responsible for the simultaneous and frequent manifestation of osteoporosis and arteriosclerosis in elderly patients.
- Subjects :
- Animals
Cardiovascular Diseases genetics
Cardiovascular Diseases mortality
Causality
Cholecalciferol deficiency
Comorbidity
Fractures, Spontaneous etiology
Fractures, Spontaneous genetics
Fractures, Spontaneous mortality
Glucuronidase
Glycoproteins genetics
Humans
Klotho Proteins
Membrane Proteins genetics
Mice
Mice, Knockout
Osteoporosis genetics
Osteoporosis mortality
Osteoprotegerin
Receptors, Cytoplasmic and Nuclear genetics
Receptors, Tumor Necrosis Factor
Risk
Spinal Fractures etiology
Spinal Fractures genetics
Spinal Fractures mortality
Cardiovascular Diseases etiology
Osteoporosis etiology
Subjects
Details
- Language :
- German
- ISSN :
- 0723-5003
- Volume :
- 98
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Medizinische Klinik (Munich, Germany : 1983)
- Publication Type :
- Academic Journal
- Accession number :
- 12928809
- Full Text :
- https://doi.org/10.1007/s00063-003-1283-8